Showing posts with label ATR gene. Show all posts
Showing posts with label ATR gene. Show all posts

Sunday, April 5, 2015

Doubling Lifespan of Mice


In 2009, it was shown by the Spanish National Cancer Research Center under Óscar Fernández-Capetillo that mice age faster with low levels of ATR protein, an essential protein for the repair of damaged DNA, Stopping the premature ageing of these mice and doubling their life span has been achieved by introducing a mutation capable of increasing the body's capacity to produce nucleotides available in the cell.

This was originally tested in yeast, Saccharomyces cerevisiae, where it proved to be true and has since been tested on mice. The mice were given two genetic alterations with the first being the original ATR gene mutation that led to premature aging and the second which was the animals had multiple copies of Rrm2, the key gene for nucleotide synthesis. The results showed the aging process to be significantly slowed in these mice, taking their life span from 24 weeks to 50 weeks.

Every genome has weak or fragile sections which break spontaneously. These fragile sections have been shown to be involved in human diseases like cancer. The research paper showed that those mice with additional copies of Rrm2 suffered less DNA breaks in these fragile areas. "The question we are asking ourselves now is whether an increase in the capacity to produce nucleotides could also lengthen life expectancy in normal animals without premature ageing," says Fernández-Capetillo.

I found this article very interesting due to the research of prolonging and increasing the life span of animals. Although it is not said in the article I think it goes without saying that the obvious implications of a study like this is to eventually see if causing these same mutations in humans could lead to longer and healthier life spans.



Monday, April 16, 2012

Gene linked to throat cancer

A recent study by researchers in London and Japan identified a specific gene linked to throat cancer. For the duration of the study, the researchers followed ten members who developed the condition. The ATR gene found in humans was responsible for this phenomenon. If abnormalities were in the ATR gene were present, characteristics of hair loss, dilated vessels, and teeth and nail defects were also an indication of the caner nearing existence in the patient, and nearly all of the patients who developed throat cancer obtained those symptoms. To further conform the diagnosis, researchers took blood samples from the effected patients, and from patients that were unaffected. “Professor John McGrath from the King's College London Genetic Skin Disease Group at St John's Institute of Dermatology, based at Guy's Hospital, said: 'This is an intriguing study which not only provides a genetic explanation for an unusual syndrome, but also provides a unique novel insight into how the ATR gene may be associated with a specific form of cancer. It is a classic example of how we can use rare conditions to give us insight into more common diseases.” Now that the scientist know the gene that causes throat cancer, researchers can now look for specific solutions to correct the gene.